Ritchie Centre for Baby Health Research, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Respirology. 2010 Feb;15(2):326-35. doi: 10.1111/j.1440-1843.2009.01689.x.
This article investigates a new acoustic device to assess the behaviour of the upper airway in patients with OSA. Currently there is no simple non-invasive method to perform such measurements. As such this paper describes the device in probing the patency of the airway during sleep and increasing the efficiency of diagnosing OSA.
OSA is a common disorder resulting in health and economic burdens. Currently identifying OSA in patients involves expensive techniques that require overnight studies in a laboratory setting with qualified staff. This paper tests a new acoustic device (AirwayClear (AC)) for assessing upper airway patency in human subjects with OSA. We hypothesize that obstructive apnoeas would be detected equally well with AC and polysomnography (PSG).
Twenty-three patients with severe OSA underwent an overnight CPAP titration study. We introduced pseudorandom noise (600-1200 Hz) using AC to the patient's nasal mask during 1 h of subtherapeutic CPAP. AC determined a measure of airway patency based on the level of pseudorandom noise reaching a sternal notch sensor. The ability of AC to detect obstructive respiratory events was compared with standard PSG.
Three hundred and twenty-two obstructive events (obstructive and mixed apnoeas) were identified by PSG. AC scored 80% as complete obstructions and 16% as partial obstructions. Conversely, AC detected 281 complete obstructions. PSG recognized 84% as apnoeas and scored 11% as hypopnoeas. Of the 204 hypopnoeas identified with PSG, AC indicated the airway was partially or completely obstructed in 69% of patients. A Bland-Altman analysis for the apnoeas from the two measures showed a mean difference of 2.3 events/h and 95% confidence intervals of +/-15.5 events/h.
We conclude that AC is able to track airway patency and to identify airway closure in patients with OSA.
本文研究了一种新的声学设备,以评估阻塞性睡眠呼吸暂停(OSA)患者上呼吸道的功能。目前,尚无简单的非侵入性方法进行此类测量。因此,本文介绍了一种在睡眠期间探测气道通畅性并提高 OSA 诊断效率的设备。
OSA 是一种常见的疾病,会对健康和经济造成负担。目前,识别 OSA 患者需要昂贵的技术,需要在有资质的工作人员的实验室环境中进行过夜研究。本文测试了一种新的声学设备(AirwayClear(AC)),用于评估 OSA 患者的上呼吸道通畅性。我们假设 AC 与多导睡眠图(PSG)一样能够很好地检测到阻塞性呼吸暂停。
23 例重度 OSA 患者接受了一夜 CPAP 滴定研究。我们在亚治疗 CPAP 期间通过 AC 向患者的鼻罩中引入伪随机噪声(600-1200 Hz)。AC 根据伪随机噪声到达胸骨切迹传感器的水平确定气道通畅性的度量。AC 检测阻塞性呼吸事件的能力与标准 PSG 进行了比较。
PSG 共识别出 322 次阻塞性事件(阻塞性和混合性呼吸暂停)。AC 对完全阻塞的评分率为 80%,部分阻塞的评分率为 16%。相反,AC 检测到 281 次完全阻塞。PSG 将 84%识别为呼吸暂停,并将 11%评为低通气。在 PSG 识别出的 204 次低通气中,AC 指示气道在 69%的患者中部分或完全阻塞。两种测量方法的呼吸暂停平均差异为 2.3 次/h,95%置信区间为 +/-15.5 次/h。
我们得出结论,AC 能够跟踪气道通畅性并识别 OSA 患者的气道关闭。